COVID-19 and vitamin D supplementation: Is there any evidence based to reduce the risk?
Several studies and meta-analysis suggest that vitamin D deficiency constitutes a risk factor for acute respiratory infections while supplementation may reduce this risk. Given the current context of the COVID-19 pandemic, the role of vitamin D supplementation in the prevention and improvement of the prognosis of affected patients has been suggested by some studies and refuted by others. Through this article, we report the mechanisms of action and properties of vitamin D, and we discuss the different hypotheses of the involvement of vitamin D in respiratory infections, especially Covid-19 in the light of the most recent published data.
Keywords
How to Cite
Similar Articles
- Assessment of vitamin A levels in breast milk and serum of lactating mothers in Southeast Nigeria
- Efficacy of Moringa Soy Milk as a Food-Based Intervention on Hemoglobin Levels in Anemic Pregnant Women: A Quasi-Experimental Study in Gorontalo, Indonesia
- Nutrition and food security in Mali from 2010 to 2020
- Update of the nutritional situation in the Republic of the Sudan
- An overview on the nutrition transition and its health implications: Tunisia case
- Evaluation of Nutritional Status Among COVID-19 Patients Admitted to the Intensive Care Unit in Jeddah, Saudi Arabia: A Cross-Sectional Observational Study
- Overview on cardiometabolic associated factors in COVID-19 patients: a narrative review
- Seed from olive cake prevents hyperglycemia, hyperlipidemia, and oxidative stress in dexamethasone-induced diabetes rats
- COVID-19 lockdown impact on Tunisian consumer behaviors and awareness related to food consumption and wastage during celebrations: Case of study “Ramadan month”
- Effects of the Withania somnifera supplementation on sports performance: a systematic review and meta-analysis
You may also start an advanced similarity search for this article.

NAJFNR is licensed under